Clinical trial designs for evaluating and exploiting cancer evolution (vol 118, 101583, 2023)

被引：0
|
作者：
Garces, Alvaro H. Ingles [1 ,2 ]
Porta, Nuria [3 ]
Graham, Trevor A. [4 ]
Banerji, Udai [1 ,2 ,5 ]
机构：
[1] Inst Canc Res, Drug Dev Unit, London, England
[2] Royal Marsden NHS Fdn Trust, London, England
[3] Inst Canc Res, Clin Trials & Stat Unit, London, England
[4] Inst Canc Res, Ctr Evolut & Canc, London, England
[5] Royal Marsden NHS Fdn Trust, Drug Dev Unit, Downs Rd, Sutton SM2 5PT, England
来源：
CANCER TREATMENT REVIEWS | 2023年 / 119卷
关键词：
D O I：
10.1016/j.ctrv.2023.102596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical trial designs for evaluating and exploiting cancer evolution
    Garces, Alvaro H. Ingles
    Porta, Nuria
    Graham, Trevor A.
    Banerji, Udai
    CANCER TREATMENT REVIEWS, 2023, 118
  • [2] Evaluating Clinical Trial Designs for Investigational Treatments of Ebola Virus Disease
    Cooper, Ben S.
    Boni, Maciej F.
    Pan-ngum, Wirichada
    Day, Nicholas P. J.
    Horby, Peter W.
    Olliaro, Piero
    Lang, Trudie
    White, Nicholas J.
    White, Lisa J.
    Whitehead, John
    PLOS MEDICINE, 2015, 12 (04)
  • [3] An evaluation of phase I cancer clinical trial designs
    Ahn, C
    STATISTICS IN MEDICINE, 1998, 17 (14) : 1537 - 1549
  • [4] PRECISION MEDICINE IN KIDNEY CANCER AND CLINICAL TRIAL DESIGNS
    Larkin, J.
    Okines, A.
    ANNALS OF ONCOLOGY, 2014, 25
  • [5] Clinical trial designs for the early clinical development of therapeutic cancer vaccines
    Simon, RM
    Steinberg, SM
    Hamilton, M
    Hildesheim, A
    Khleif, S
    Kwak, LW
    Mackall, CL
    Schlom, J
    Topalian, SL
    Berzofsky, JA
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1848 - 1854
  • [6] Clinical trial designs for evaluating the medical utility of prognostic and predictive biomarkers in oncology
    Simon, Richard
    PERSONALIZED MEDICINE, 2010, 7 (01) : 33 - 47
  • [7] The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review
    Meyer, Elias Laurin
    Mesenbrink, Peter
    Dunger-Baldauf, Cornelia
    Fulle, Hans-Jurgen
    Glimm, Ekkehard
    Li, Yuhan
    Posch, Martin
    Konig, Franz
    CLINICAL THERAPEUTICS, 2020, 42 (07) : 1330 - 1360
  • [8] Clinical trial designs for the approval of rare cancer drugs in Japan
    Noguchi, E.
    Yonemori, K.
    Shimoi, T.
    Yunokawa, M.
    Okuma, H. S.
    Kawachi, A.
    Kitano, A.
    Nishikawa, T.
    Shimomura, A.
    Shimizu, C.
    Takiguchi, Y.
    Kawai, A.
    Fujiwara, Y.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2016, 27
  • [9] Window of opportunity clinical trial designs to study cancer metabolism
    Francesca Aroldi
    Simon R. Lord
    British Journal of Cancer, 2020, 122 : 45 - 51
  • [10] Adaptive clinical trial designs for phase I cancer studies
    Sverdlov, Oleksandr
    Wong, Weng Kee
    Ryeznik, Yevgen
    STATISTICS SURVEYS, 2014, 8 : 2 - 44
12345